Zoetis Publishes Q3 2026 Earnings Call Transcript
Bitget2026/11/06 14:49- Zoetis narrowed 2026 revenue guidance to $9.22 billion-$9.32 billion, raising adjusted diluted EPS guidance to $6.25-$6.35.
- CEO Kristin Peck, CFO and COO James Saccaro attended the November 5 third-quarter earnings call with corporate finance chief Mathieu Aussermeier.
- Quarterly revenue fell 1% to $2.4 billion; adjusted net income declined 7% on an organic operational basis to $720 million.
- Dermatology sales dropped 16% to $396 million as competition weighed; promotions slowed US share losses to 4 points from 7 points.
- Management expects competitive pressures through most of 2027, assumes no macroeconomic improvement and anticipates limited revenue contributions from new launches.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Korean stocks rise by 1.84%
Despite financing pressure, outstanding execution prevails; Citi maintains “Buy” rating on CoreWeave (CRWV.US) with a price target raised to $128.
Citi stated in a research report that CoreWeave has significantly outperformed expectations in terms of revenue, capacity, pricing, and profitability, demonstrating "outstanding execution within controllable range." Based on this, Citi maintains its "Buy/High Risk" rating and sets a target price of $128.
TSMC (TSM.US) personally invests in AI: spends $1 billion to acquire shares in Anthropic and OpenAI, entering the trillion-dollar IPO high-stakes arena
TSMC plans to invest up to $1 billion in both Anthropic and OpenAI, allocating $500 million to each company. The company's annual revenue is expected to increase by approximately 44%, with strong demand for AI chips continuing.
Correction to Barrick Article
Crypto prices
More
